AtriCure, Inc.

NasdaqGM:ATRC

Market Cap

USD 1.59 B

Share Price

USD 32.06

Avg Daily Volume

556,966

Change (1 day)

0.44%

Change (1 year)

44.48%

Change (YTD)

4.91%

AtriCure, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: -6.45%

AtriCure, Inc. EBIT Margin is -6.45% for the Trailing 12 Months (TTM) ending March 31, 2025, a -9.60% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • AtriCure, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was -7.13%, a -21.78% change year over year.
  • AtriCure, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -9.12%, a -47.87% change year over year.
  • AtriCure, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was -17.49%, a -14.89% change year over year.
  • AtriCure, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was -20.55%, a 14.33% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin